Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies

Journal of Pharmaceutical Sciences(2023)10.1016/j.xphs.2023.05.014Source: DataRank Database

Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies is a research paper published in Journal of Pharmaceutical Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.27)OA: bronzeTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Nicole L. Jarvi ORCID,Sathy V. Balu‐Iyer ORCID,Nhan H. Nguyen ORCID

Live enrichment

PubMed:37220828 OpenAlex:https://openalex.org/W4377195376

National Institute of Allergy and Infectious Diseases

Grant: AI-169296

National Institutes of Health

Grant: HL-70227

National Heart Lung and Blood Institute

Grant: HL161818

NIAID NIH HHS

Grant: R01 AI169296

NHLBI NIH HHS

Grant: R61 HL161818

FWCI

1.27

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://jpharmsci.org/article/S0022354923002010/pdf

publisherhttp://jpharmsci.org/article/S0022354923002010/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022354923002010?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022354923002010?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.xphs.2023.05.014

Fields of Study

Hemophilia Treatment and ResearchPlatelet Disorders and TreatmentsCAR-T cell therapy research

MeSH Terms

Factor VIIIHemophilia AHumansRecombinant ProteinsTreatment OutcomeAntibodies, Bispecific

Keywords

ImmunogenicityMedicineModalitiesGenetic enhancementTherapeutic modalitiesPEGylationIntensive care medicineImmunologyImmune systemInternal medicineBiologyGeneIn vivoBiotechnologyInhibitorsFactor VIIICell-based TherapyImmune Tolerance InductionTherapeutic ProteinsGene Replacement TherapyGene Editing TherapyBiological Modalities

Sustainable Development Goals

SDG 0: Good health and well-being